HomeCompareBLVAX vs ORCC

BLVAX vs ORCC: Dividend Comparison 2026

BLVAX yields 17.54% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLVAX wins by $41.3K in total portfolio value
10 years
BLVAX
BLVAX
● Live price
17.54%
Share price
$11.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62.7K
Annual income
$5,136.87
Full BLVAX calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — BLVAX vs ORCC

📍 BLVAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBLVAXORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BLVAX + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BLVAX pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLVAX
Annual income on $10K today (after 15% tax)
$1,491.23/yr
After 10yr DRIP, annual income (after tax)
$4,366.34/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, BLVAX beats the other by $4,365.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLVAX + ORCC for your $10,000?

BLVAX: 50%ORCC: 50%
100% ORCC50/50100% BLVAX
Portfolio after 10yr
$42.1K
Annual income
$2,568.96/yr
Blended yield
6.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

BLVAX
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLVAX buys
0
ORCC buys
0
No recent congressional trades found for BLVAX or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBLVAXORCC
Forward yield17.54%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$62.7K$21.4K
Annual income after 10y$5,136.87$1.04
Total dividends collected$33.2K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: BLVAX vs ORCC ($10,000, DRIP)

YearBLVAX PortfolioBLVAX Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$12,454$1,754.39$11,190$489.61+$1.3KBLVAX
2$15,368$2,042.04$12,229$256.01+$3.1KBLVAX
3$18,799$2,354.95$13,216$130.74+$5.6KBLVAX
4$22,807$2,692.20$14,207$66.02+$8.6KBLVAX
5$27,456$3,052.53$15,234$33.17+$12.2KBLVAX
6$32,812$3,434.36$16,317$16.62+$16.5KBLVAX
7$38,945$3,835.84$17,468$8.32+$21.5KBLVAX
8$45,926$4,254.92$18,695$4.16+$27.2KBLVAX
9$53,830$4,689.38$20,006$2.08+$33.8KBLVAX
10$62,735$5,136.87$21,407$1.04+$41.3KBLVAX

BLVAX vs ORCC: Complete Analysis 2026

BLVAXStock

The fund invests at least 80% of its assets in a broadly diversified portfolio of common stocks of large-sized U.S. companies similar in size, at the time of purchase, to those within the Russell 1000® Index. Columbia selects low volatility, undervalued stocks using a unique approach which combines the use of proprietary analytical tools and the qualitative judgments of the investment team. This strategy seeks to provide the fund with lower downside risk and meaningful upside participation relative to the Russell 1000® Index.

Full BLVAX Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this BLVAX vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLVAX vs SCHDBLVAX vs JEPIBLVAX vs OBLVAX vs KOBLVAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.